Jane Gross, PhD

Senior Vice President & Chief Scientific Officer, Aptevo Therapeutics Inc.

Dr. Gross leads research and non-clinical development focusing on the development of novel protein therapeutics based on the ADAPTIRâ„¢ platform, a position she has held for the last five years at Emergent. She leads research efforts in molecular biology andprotein engineering, immunology, protein and cell sciences, and translational research for clinical development. Dr. Gross has a Ph.D. in Immunology and over twenty-five years of experience in the discovery and development of novel protein therapeutics inautoimmune, infectious disease and oncology indications and is an inventor on over 100 patents. Prior to joining Emergent, Dr. Gross served as VP of Immunology Research at ZymoGenetics Inc., where she led efforts in discovery and development of therapeutics from novel genes for treatment of AIID and cancer.